about
A Modular Vaccine Development Platform Based on Sortase-Mediated Site-Specific Tagging of Antigens onto Virus-Like ParticlesChimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms.Beta-Propiolactone Inactivation of Coxsackievirus A16 Induces Structural Alteration and Surface Modification of Viral CapsidsA bivalent virus-like particle based vaccine induces a balanced antibody response against both enterovirus 71 and norovirus in mice.Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge.Coxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in mice.High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice.A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles.Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody.A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.Coxsackievirus A10 atomic structure facilitating the discovery of a broad-spectrum inhibitor against human enterovirusesA Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural InfectionRecombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization epitope induces protective immunity in miceIdentification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection
P50
Q28834387-8D84D257-CE06-4103-989A-98160A645246Q37547757-4E34FD50-C660-4D0A-825F-1CDB729EF971Q38763206-5A27C581-5629-4E44-B7B6-AA18AB9BB45CQ38831138-CD65AA5A-58CD-45D3-BFCA-948BA4CE6875Q40562925-07475FAE-D055-4452-96B7-E945DE0E99A7Q40782188-6FFB77A2-395B-4825-9825-25CE5A54E77EQ41373115-011EEB32-833A-4A62-8D6A-A8E3E8F7227CQ46270646-70EE669A-4368-4A20-8921-32E8DECCBB62Q47610511-8BC980D5-A792-4BD7-B2EA-B9F22049F693Q55099892-9FEE721A-2A33-47C6-8F4B-C11B0F9B0726Q60907989-6D56154F-AC78-43FE-9637-5A046BA78B7FQ90068199-583FFEB3-EB9D-4AE9-BDC0-78103FD60CD4Q92008487-ED69725E-DDC0-464B-BD9A-2E847A3947EFQ92252211-C3841B00-9AF2-4438-8D1C-A4E10FD011C2
P50
description
researcher (ORCID 0000-0002-2300-4739)
@en
name
Xiaohua Ye
@en
type
label
Xiaohua Ye
@en
prefLabel
Xiaohua Ye
@en
P31
P496
0000-0002-2300-4739